GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quest PharmaTech Inc (TSXV:QPT) » Definitions » Accumulated other comprehensive income (loss)

Quest PharmaTech (TSXV:QPT) Accumulated other comprehensive income (loss) : C$-0.11 Mil (As of Oct. 2023)


View and export this data going back to 1999. Start your Free Trial

What is Quest PharmaTech Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Quest PharmaTech's Accumulated other comprehensive income (loss) for the quarter that ended in Oct. 2023 was C$-0.11 Mil.

Quest PharmaTech's quarterly Accumulated other comprehensive income (loss) stayed the same from Apr. 2023 (C$-0.11 Mil) to Jul. 2023 (C$-0.11 Mil) and stayed the same from Jul. 2023 (C$-0.11 Mil) to Oct. 2023 (C$-0.11 Mil).

Quest PharmaTech's annual Accumulated other comprehensive income (loss) declined from Jan. 2021 (C$0.00 Mil) to Jan. 2022 (C$-0.05 Mil) and declined from Jan. 2022 (C$-0.05 Mil) to Jan. 2023 (C$-0.11 Mil).

Quest PharmaTech Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Quest PharmaTech's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest PharmaTech Accumulated other comprehensive income (loss) Chart

Quest PharmaTech Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.19 0.85 - -0.05 -0.11

Quest PharmaTech Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.05 -0.11 -0.11 -0.11 -0.11

Quest PharmaTech Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Quest PharmaTech Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Quest PharmaTech's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Quest PharmaTech (TSXV:QPT) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quest PharmaTech Inc (TSXV:QPT) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
TSXV:IOT TSXV:RKV TSXV:IBO XCNQ:MESC TSXV:MRVL TSX:APLI XCNQ:AGN XCNQ:MBIO TSXV:HEM XCNQ:DRUG OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
N/A
Address
8123 Roper Road NW, Edmonton, AB, CAN, T6E 6S4
Website
http://www.questpharmatech.com
Quest PharmaTech Inc is a Canadian-based pharmaceutical company developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target- truncated O-glycans on MUC16 discovered at the University of Nebraska Medical Center. The company is also developing products utilizing proprietary transdermal delivery technologies with a focus on dermatology and wound healing applications.
Executives
Ragupathy Madiyalakan Director

Quest PharmaTech (TSXV:QPT) Headlines

No Headlines